Skip to content

Clinical trials

Phase 1 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 1 Clear all

146 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20045
20053
20069
20076
200811
20097
20109
20116
20122
20132
20143
20153
20167
20172
20184
20198
20205
20216
20227
20239
202412
202511
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status18
Recruiting10
Withdrawn9
Terminated7
Not yet recruiting4
Active, not recruiting4
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline17
Northwestern University4
MetroHealth Medical Center3
National Center for Complementary and Integrative Health (NCCIH)3
National Institute of Mental Health (NIMH)3
University of Oxford3
VA Office of Research and Development3
AstraZeneca2
Brown University2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders146
Stress Disorders, Post-Traumatic15
Depressive Disorder13
Pain11
Neoplasms9
Major Depressive Disorder6
Sleep Initiation and Maintenance Disorders6
Substance-Related Disorders6
Alcoholism4
Mental Disorders4

Trials

Showing 1 to 25 of 146. Each trial links to its page on Pharma Observatory.

46 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.